Cold Urticaria: <i>RECOGNITION AND CHARACTERIZATION OF A NEUTROPHIL CHEMOTACTIC FACTOR WHICH APPEARS IN SERUM DURING EXPERIMENTAL COLD CHALLENGE</i>

Stephen I. Wasserman; Nicholas A. Soter; David M. Center; K. Frank Austen

doi:10.1172/JCI108756

Cold Urticaria: RECOGNITION AND CHARACTERIZATION OF A NEUTROPHIL CHEMOTACTIC FACTOR WHICH APPEARS IN SERUM DURING EXPERIMENTAL COLD CHALLENGE

Stephen I. Wasserman, Nicholas A. Soter, David M. Center, and K. Frank Austen

Published July 1, 1977 - More info

View PDF

Abstract

Sera were obtained from the venous effluents of cold-challenged arms of patients with idiopathic cold urticaria without plasma or serum cryoproteins; these sera exhibited increased neutrophil chemotactic activity without alterations of the complement system. A two- to fourfold augmentation of the base-line neutrophil chemotactic activity of serum from the immersed extremity began within 1 min, peaked at 2 min, and returned to base-line levels within 15 min, whereas there was no change in the serum chemotactic activity in the control arm. The augmented chemotactic activity in the serum specimens from the challenged arm of each patient appeared in a high molecular-weight region, as assessed by the difference in activity recovered after Sephadex G-200 gel filtration of the paired lesional and control specimens. Sequential purification of this high molecular-weight activity by anion- and cation-exchange chromatography revealed a single peak of activity at both steps. The partially purified material continued to exhibit a high molecular weight, being excluded on Sepharose 4B, and had a neutral isoelectric point. The partially purified material showed a preferential chemotactic activity for neutrophilic polymorphonuclear leukocytes, required a gradient for expression of this function, and exhibited a capacity to deactivate this cell type. This active principle, termed high molecular-weight neutrophil chemotactic factor, exhibited a time-course of release that could be superimposed upon that of histamine and the low molecular-weight eosinophil chemotactic factor and may represent another mast cell-derived mediator.